Obituaries

Josef Warkany, known as the father of modern teratology—the study of birth defects—died June 22 at the age of 90 in Clifton, Ohio. Born in Vienna and a graduate of the University of Vienna, Warkany left his homeland in 1931. He settled in Cincinnati, and spent his entire career at the University of Cincinnati's Children's Hospital Research Foundation. Warkany was one of the first pediatricians to focus on the first nine months after conception. He identified the crippling disease of

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Josef Warkany, known as the father of modern teratology—the study of birth defects—died June 22 at the age of 90 in Clifton, Ohio. Born in Vienna and a graduate of the University of Vienna, Warkany left his homeland in 1931. He settled in Cincinnati, and spent his entire career at the University of Cincinnati's Children's Hospital Research Foundation. Warkany was one of the first pediatricians to focus on the first nine months after conception. He identified the crippling disease of acrodynia and assisted in developing its cure. Acrodynia is a rare fetal disease that is characterized by a pink discoloration of the limbs, hair and teeth loss, hypertension, and weight loss; the disease is sometimes fatal. In the 1940s, Warkany also helped prove that diet and environmental factors are a large part of fetal health. Warkany's best-known work is a 1,300-page pediatric text called Congenital Malformations (Chicago, Year Book Medical ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies